|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/06 | (2013.01) |
| C07D 211/36 | (2006.01) | ||
| C07D 401/06 | (2006.01) | ||
| C07D 211/36 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| C07D 405/06 | (2006.01) | ||
| C07D 205/04 | (2013.01) | ||
| C07D 417/06 | (2006.01) | ||
| C07D 205/04 | (2006.01) | ||
| C07D 207/14 | (2013.01) | ||
| C07D 207/14 | (2006.01) | ||
| C07D 211/56 | (2013.01) | ||
| C07D 211/56 | (2006.01) | ||
| C07D 401/06 | (2013.01) | ||
| C07D 401/10 | (2006.01) | ||
| C07D 401/10 | (2013.01) | ||
| C07D 401/14 | (2006.01) | ||
| C07D 401/14 | (2013.01) | ||
| C07D 403/06 | (2006.01) | ||
| C07D 403/06 | (2013.01) | ||
| C07D 405/10 | (2006.01) | ||
| C07D 405/10 | (2013.01) | ||
| C07D 405/12 | (2006.01) | ||
| C07D 405/12 | (2013.01) | ||
| C07D 413/06 | (2013.01) | ||
| C07D 413/06 | (2006.01) | ||
| C07D 417/06 | (2013.01) | ||
| C07D 417/14 | (2006.01) | ||
| C07D 417/14 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 31/435 | (2006.01) |
| (11) | Number of the document | 3661923 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18762939.9 |
| Date of filing the European patent application | 2018-08-02 | |
| (97) | Date of publication of the European application | 2020-06-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2018/029696 |
| Date | 2018-08-02 |
| (87) | Number | WO 2019/027058 |
| Date | 2019-02-07 |
| (30) | Number | Date | Country code |
| 2017150685 | 2017-08-03 | JP | |
| 2017248495 | 2017-12-25 | JP |
| (72) |
KAJITA, Yuichi , JP
MIKAMI, Satoshi , JP
MIYANOHANA, Yuhei , JP
KOIKE, Tatsuki , JP
DAINI, Masaki , JP
OYABU, Norio , JP
OGINO, Masaki , JP
TAKEUCHI, Kohei , JP
ITO, Yoshiteru , JP
TOKUNAGA, Norihito , JP
SUGIMOTO, Takahiro , JP
MIYAZAKI,Tohru , JP
ODA, Tsuneo , JP
HOASHI, Yasutaka , JP
HATTORI,Yasushi , JP
IMAMURA, Keisuke , JP
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1 Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
|
| (54) | N-HETEROCYCLIC COMPOUNDS AS OREXIN 2 AGONISTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| N-HETEROCYCLIC COMPOUNDS AS OREXIN 2 AGONISTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |